Antidepressant Class, Age, and the Risk of Deliberate Self-Harm: A Propensity Score Matched Cohort Study of SSRI and SNRI Users in the USA
Authors:
- 22 October 2013
- journal article
- research article
- Published by Springer Nature in CNS Drugs
- Vol. 28 (1) , 79-88
Abstract
The US Food and Drug Administration’s meta-analyses of placebo-controlled antidepressant trials found approximately twice the rate of suicidal behaviors among children and adults aged 24 years and younger who were randomized to receive antidepressant medication than among those who were randomized to placebo. Rates of suicidal behavior were similar for subjects aged 25–64 years whether they received antidepressants or placebo, and subjects aged 65 years or older randomized to antidepressants were found to have lower rates of suicidal behavior. The age-stratified FDA meta-analyses did not have adequate power to investigate rates of suicidal behaviors by antidepressant drug class.Keywords
This publication has 34 references indexed in Scilit:
- Antidepressant Agents and Suicide Death Among US Department of Veterans Affairs Patients in Depression TreatmentJournal of Clinical Psychopharmacology, 2012
- Comparative Safety of Antidepressant Agents for Children and Adolescents Regarding Suicidal ActsPediatrics, 2010
- Variation in the Risk of Suicide Attempts and Completed Suicides by Antidepressant Agent in AdultsArchives of General Psychiatry, 2010
- Comorbid anxiety as a suicide risk factor among depressed veteransDepression and Anxiety, 2009
- Sleep problems and suicidality in the National Comorbidity Survey ReplicationJournal of Psychiatric Research, 2009
- Risk of suicide during treatment with venlafaxine, citalopram, fluoxetine, and dothiepin: retrospective cohort studyBMJ, 2006
- Antidepressant Adherence and Suicide Risk in Depressed YouthAmerican Journal of Psychiatry, 2005
- Antidepressant treatment and the risk of fatal and non-fatal self harm in first episode depression: nested case-control studyBMJ, 2005
- Antidepressant Drugs and the Emergence of Suicidal TendenciesDrug Safety, 1993
- The Importance of Beta, the Type II Error and Sample Size in the Design and Interpretation of the Randomized Control TrialNew England Journal of Medicine, 1978